Alphatec Holdings (ATEC) Depreciation & Amortization (CF) (2010 - 2026)
Alphatec Holdings (ATEC) reported Depreciation & Amortization (CF) of $19.1 million for Q1 2026, down 3.88% on a YoY basis from $19.9 million in Q1 2025, and little changed sequentially from $19.1 million in Q4 2025.
Alphatec Holdings (ATEC) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $19.1 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 3.88% year-over-year to $19.1 million; the trailing twelve-month figure through Mar 2026 stood at $76.7 million (down 4.62% YoY), and the FY2025 full-year result was $77.5 million, down 1.18% from the prior year.
- Depreciation & Amortization (CF) held at $19.1 million in Q1 2026, from $19.1 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $20.6 million in Q3 2024 to a low of $9.3 million in Q1 2022.
- A 5-year average of $16.0 million and a median of $17.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 141.95% in 2022 and decreased 7.23% in 2025, its largest moves.
- Tracing ATEC's Depreciation & Amortization (CF) over 5 years: stood at $11.3 million in 2022, then soared by 41.15% to $16.0 million in 2023, then rose by 24.9% to $20.0 million in 2024, then slipped by 4.53% to $19.1 million in 2025, then increased by 0.18% to $19.1 million in 2026.
- Business Quant data shows ATEC's Depreciation & Amortization (CF) at $19.1 million in Q1 2026, $19.1 million in Q4 2025, and $19.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 19.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.14 Mn |
| Mar 31, 2026 | 19.14 Mn |
| Dec 31, 2025 | 19.10 Mn |
| Dec 31, 2025 | 19.10 Mn |
| Sep 30, 2025 | 19.16 Mn |
| Sep 30, 2025 | 19.16 Mn |
| Jun 30, 2025 | 19.33 Mn |
| Jun 30, 2025 | 19.33 Mn |
| Mar 31, 2025 | 19.91 Mn |
| Mar 31, 2025 | 19.91 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 20.65 Mn |
| Sep 30, 2024 | 20.65 Mn |
| Jun 30, 2024 | 19.88 Mn |
| Jun 30, 2024 | 19.88 Mn |
| Mar 31, 2024 | 17.89 Mn |
| Mar 31, 2024 | 17.89 Mn |
| Dec 31, 2023 | 16.02 Mn |
| Dec 31, 2023 | 16.02 Mn |